ArchiveIn 2024, FDA approved 50 new drugs, including 31 chemical small molecules and 19 biological products. This review describes the descriptions, indications, mechanism of action, dosage forms and strengths, adverse reactions, and synthesis routes of all the small molecules, and the basic information about biological products.
Peptide-drug conjugates(PDCs) are emerging targeted drugs, composed of payloads, linkers, and homing peptides. By homing peptides, cytotoxic molecules or radionuclides can be enriched in cells of diseased tissues,thereby reducing the toxicity to normal cells. With the advantages of high selectivity, high tissue penetration, and low immunogenicity, PDCs have become a hot spot in the development of a new generation of targeted antineoplastic drugs following antibody-drug conjugates(ADCs). Nevertheless, PDCs still face some challenges, such as poor in vivo stability,and low receptor affinity. This paper reviews the composition, clinical application progress, key technologies, and challenges of PDCs, aiming to provide some references for the development and application of PDCs.
Bruton’s tyrosine kinase(BTK) plays a crucial role in the development, proliferation, differentiation,activation and cytokine secretion of B cells. BTK inhibitors(BTKIs) can effectively block downstream cell signaling and receptor activation by blocking BTK or inhibiting its activity, and produce negative feedback on upstream signaling molecules related to the occurrence and development of various diseases, so as to playing a therapeutic role. In the research and development of BTKIs, the target occupancy, serving as an evaluation indicator of the binding affinity of drugs to BTK,has become an important pharmacodynamic parameter in preclinical and clinical studies. Besides, it not only reflects the relationship between dose and target occupancy, but also has important significance for establishing the relationship between efficacy and target occupancy. This paper reviews the evaluation methods of BTKI target occupancy, and discusses the advantages and disadvantages of these methods, aiming to provide some references for selecting suitable target occupancy evaluation methods in the research and development process of BTKI.
In this paper, the synthetic route of phenylephrine hydrochloride(1) was improved. 3-Hydroxyaceto-phenone(2) was used as the starting material to synthesize 2-chloro-1-(3-hydroxyphenyl)ethan-1-one(3) by reacting with sulfonyl chloride. Compound 3 was transformed into 1-(3-hydroxyphenyl)-2-[benzyl(methyl)amino]ethan-1-one(4)through nucleophilic substitution with N-methylbenzylamine. (R)-3-[2-[Benzyl(methyl)amino]-1-hydroxyethyl]phenol(5)was stereoselectively synthesized from 4 via reduction by the engineered bacteria containing carbonyl reductase A12.Compound 1 was obtained from 5 with the purity of 99.9% and ee value of up to 99.9% by palladium carbon debenzylation and salification, and the total yield reached to 62.8%(based on 2). The improved synthetic route had the characteristics of simple operation and high yield, which was suitable for industrial production.
Based on the new synthetic route of deoxycholic acid(1) reported by this group, nine related substances of 1 were prepared in this paper, including eight process impurities, i.e. related substances A(7), C(8), D(9), E(10),F(11), B(12), H(13), I(14) , and one degradation impurity J(3). Among them, compounds 8, 9 and 13 were reported at the first time. The structures of these compounds were confirmed by 1H NMR and MS.
To improve the yield of cyclosporin A(1) produced by Fusarium solani, this study optimized the types and amounts of the key components in the fermentation medium for 1 production, including the carbon source, organic nitrogen source, and amino acid by single factor experiment and Box-Behnken design coupled with response surface methodology. The optimized formulation was as follows: glucose 31.3 g/L, maltodextrin 62.7 g/L, casein 17.3 g/L, yeast extract LM801 8.7 g/L, L-valine 7.15 g/L. Under these conditions, the yield of 1 by shake flask culture was increased to 4 283 mg/L. Then, the effects of different supplementation processes on the yield of 1 were investigated. Finally, the yield of 1 reached to 5 247 mg/L in a 25 L fermentor using fluid-feeding, which was 72.49% higher than that of the original formulation.This study provided some references for the industrial production of 1.
Nimodipine(1) solid dispersion(SD) was prepared by hot melt extrusion, and the tablets based on 1-SD were prepared by direct compression method. Taking the in vitro dissolution as an indicator, the impacts of filler type,type and amount of disintegrants on drug dissolution of 1-SD tablets were investigated. The results showed that the tablets prepared with potassium dihydrogen phosphate as the filler and the effervescent agent[m(sodium bicarbonate)∶m(citric acid)=5∶4] as the disintegrant exhibited a favorable dissolution behavior. The 1-SD tablets prepared with the optimized formulation(containing 240 mg of 1-SD, 124 mg of potassium dihydrogen phosphate, 32 mg of above disintegrant, and 4 mg of magnesium stearate) disintegrated in 5 min, and their dissolution rate at 10 min could be over 95%. The 1-SD tablets prepared in this study effectively overcame the gel barrier produced by the hydrophilic carrier and had a good dissolution performance, which provided a reference for the development of SD tablets.
In this study, the formulation of ferulic acid(1) cream was optimized by single-factor experiments combined with Box-Behnken design-response surface methodology. Subsequently, the in vitro permeation behavior of the 1 creams was investigated with excised rat skin, and its pharmacokinetics in rats was also explored. The obtained optimal formulation was as follows: the mass fractions of 1, azone, mint oil, 1,2-propanediol and PEG400 were 5.00%,10.68%, 10.03%, 9.32% and 10.00%, respectively. The results of in vitro permeation test showed that the cumulative permeation amount of the 1 cream prepared by the optimal formulation within ten hours was (470.70±24.54)μg/cm², and the permeation rate was (57.70±3.09)μg·cm–2·h–1. The results of in vivo studies indicated that after transdermal administration of the 1 cream to rats, AUC could reach to (953.90±175.30)mg·min·L–1 at 10 h, which was equivalent to that of intragastric administration at a dose of 10 mg/kg. Moreover, the plasma concentration of 1 in rats in the transdermal administration group did not show a decreasing trend within 10 h. This study demonstrated that the preparation process of 1 cream was simple and easy to be industrialized, and the prepared cream had good transdermal absorption and could release the drug stably for a long time, providing a reference for the further development and application of 1.
Coating thickness of enteric-coated tablets is a critical quality attribute. Raman mapping has unique advantages in analysis of the microstructure of pharmaceutical preparations. In this paper, Raman mapping was used to determine the coating thickness and coating uniformity of 7 batches of aspirin enteric-coated tablets from different sources,and Micro-CT three-dimensional imaging technology was used to verify the difference in coating uniformity of aspirin enteric-coated tablets. The results showed that the coating thickness was in sequence as follows: products from manufacturer A>products from manufacturer B>reference preparation>products from manufacturer C>self-made tablets E>products from manufacturer D. The coating layers of the products from manufacturer A, manufacturer B, manufacturer D and self-made tablets E were relatively uniform, and the coating uniformity of the reference preparations and the products from manufacturer C were poor, indicating that Raman spectroscopy could be used to determine the thickness of tablet coating layers and the evaluation of coating process.
The effect of crystal form on the physicochemical properties of tofacitib citrate(1) in bulk forms were studied. Two kinds of 1 crystal(formⅠ and formⅡ) were prepared by solvent crystallization method. They were characterized by PXRD, DSC/TGA and FT-IR, and their particle size distribution, equilibrium solubility and fluidity were determined. The results showed that PXRD pattern and FT-IR spectrum of formⅠwere consistent with those reported in the original patent while the DSC/TGA curves were slightly different, but the PXRD pattern, FT-IR spectrum and DSC/TGA curves of form Ⅱ were significantly different from those of form Ⅰ. The equilibrium solubilities of formⅠ and form Ⅱshowed a significant pH dependence while the dissolution rate of form Ⅱ was significantly lower than that of form Ⅰ. In addition, the particle size of form Ⅱ was obviously larger than that of form Ⅰ, and the fluidity of form Ⅱ was better than that of form Ⅰ. This research indicated that the new crystal type(form Ⅱ) of 1 might have a good application prospect in the development of sustained-release preparations.
Three levels of concentration(0.85, 1.15, 3.08 cfu/mL) of Escherichia coli suspensions were used as objects, with 100 plates in each group for colony counting, which served as the data basis for simulating the data for different numbers of test plate combined with counting. The deviations between the reported results and the true values were analyzed under different conditions. Data of 3 groups followed Poisson distribution. For the same number of test plates,the RSD of plate counts decreased with the increasing of the concentration of bacterial suspension. For the same bacterial suspension, the RSD of plate counts and the range of reported results decreased with the increasing of the number of test plates. The lower concentration of bacterial suspension, the greater coefficient of dispersion, and the higher the risk of misjudgment. Increasing the number of test plates was beneficial to improve the accuracy of microbial count resulted in low bioburden test dilution. When the combined count of colonies was no less than 4 cfu and the RSD was no more than 50%,the colony count results could provide an accurate estimate of the bioburden of the sample solution.
The intelligent equipment for pretreatment of traditional Chinese medicines(TCM) before testing is the first application of the intelligent TCM testing technology in the TCM industry, which realizes the transformation of the pretreatment of TCM detection from manual to intelligent. The intelligent equipment is composed of five modules: feed storage system, comprehensive pretreatment system, oscillation system, discharge/ultrasonic system and condensation reflux system. By investigating the precisions of quantitative liquid filling, medium heating time and medium temperature, it was proved that the intelligent equipment could meet the using requirements. With Albiziae Flos as the representative medicines,the consistency of the results between the samples processed by this intelligent equipment and the manual processing was compared, and the time consumption of multiple batches of samples were tested. The results showed that the equipment could realize the intelligent sorting of TCM pretreatment, and the online automatic cleaning of the condensing tube.Moreover, the processing efficiency of multiple batches of TCM could be increased to 94.40%.
The aim of this study was to comprehensively investigate the online cleaning effectiveness,integrity, sterility, thermal penetration, and thermal stability of the containers for low pH viral inactivation. The cleaning effectiveness was demonstrated by investigating the indicators of the rinsing water samples after online cleaning; the sealing performance was verified by pressure holding experiments; the sterility, thermal penetration and thermal stability were proved through simulated filling of the culture medium and the process temperature control tests. The results showed that after cleaning, the visible particles, pH value, conductivity, bacterial endotoxin, microbial limit and protein absorbance all met the requirements. The pressure-holding test of the low pH virus inactivation container was qualified. And the simulated sterilization culture medium was placed at (24±1)℃ for 21 days for simulating the virus inactivation. During the examination period, the tank temperature was stable at (24.0±0.2)℃, indicating good sterility, thermal penetration and thermal stability. These results indicated that the containers for low pH viral inactivation met the production requirements and could ensure the reliability during the viral inactivation process. This study provided a reference for the validation of GMP and process requirements of the containers for low pH viral inactivation.